NYSE:MMI - Marcus & Millichap Stock Price, Price Target & More

Marcus & Millichap trades on the New York Stock Exchange (NYSE) under the ticker symbol "MMI."

Marcus & Millichap Inc (NYSE:MMI) released its quarterly earnings results on Tuesday, May, 8th. The real estate investment trust reported $0.46 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.38 by $0.08. The real estate investment trust had revenue of $174.54 million for the quarter, compared to the consensus estimate of $160.85 million. Marcus & Millichap had a net margin of 7.76% and a return on equity of 22.22%. The company's quarterly revenue was up 13.9% on a year-over-year basis. During the same period last year, the firm earned $0.31 earnings per share. View Marcus & Millichap's Earnings History.

4 equities research analysts have issued 1-year price objectives for Marcus & Millichap's shares. Their predictions range from $37.00 to $46.00. On average, they anticipate Marcus & Millichap's stock price to reach $41.50 in the next year. This suggests a possible upside of 2.8% from the stock's current price. View Analyst Ratings for Marcus & Millichap.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Marcus & Millichap in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Some companies that are related to Marcus & Millichap include ILG (ILG), Marriott Vacations Worldwide (VAC), Realogy (RLGY), Newmark Group (NMRK), Redfin (RDFN), Bluegreen Vacations (BXG), Re/Max (RMAX) and Novation Companies (NOVC).

Media headlines about MMI stock have trended somewhat positive recently, Accern Sentiment reports. The research group identifies positive and negative media coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Marcus & Millichap earned a daily sentiment score of 0.06 on Accern's scale. They also gave news articles about the real estate investment trust an impact score of 46.21 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the immediate future.

Marcus & Millichap's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include MARCUS GEORGE M (46.30%), Cambiar Investors LLC (0.41%) and Campbell & CO Investment Adviser LLC (0.02%). Company insiders that own Marcus & Millichap stock include George M Marcus, Hessam Nadji, Martin E Louie, Phoenix Investments Holdings L and William E Hughes. View Institutional Ownership Trends for Marcus & Millichap.

MMI stock was sold by a variety of institutional investors in the last quarter, including Cambiar Investors LLC. Company insiders that have sold Marcus & Millichap company stock in the last year include George M Marcus, Hessam Nadji, Martin E Louie, Phoenix Investments Holdings L and William E Hughes. View Insider Buying and Selling for Marcus & Millichap.

MMI stock was bought by a variety of institutional investors in the last quarter, including Campbell & CO Investment Adviser LLC. View Insider Buying and Selling for Marcus & Millichap.

Shares of MMI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of MMI stock can currently be purchased for approximately $40.38.

Marcus & Millichap has a market capitalization of $1.56 billion and generates $719.70 million in revenue each year. The real estate investment trust earns $51.52 million in net income (profit) each year or $1.62 on an earnings per share basis. Marcus & Millichap employs 774 workers across the globe.

Marcus & Millichap's mailing address is 23975 PARK SORRENTO SUITE 400, CALABASAS CA, 91302. The real estate investment trust can be reached via phone at 818-212-2250 or via email at [email protected]